Basel Medical (BMGL) Common Equity (2024 - 2025)

Basel Medical (BMGL) posted Common Equity of $5.0 million for Q4 2025, up 20.5% sequentially from $4.2 million in Q2 2025.

Basel Medical (BMGL) Common Equity (2024 - 2025) Analysis & Trends

Basel Medical has reported Common Equity for 2 years, with the latest figure at $5.0 million in Q4 2025.

Quarterly Common Equity changed N/A year-over-year to $5.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.0 million (changed N/A YoY) and the FY2025 annual result came in at $4.1 million, down 26.44% from the prior year.
Common Equity grew to $5.0 million in Q4 2025 per BMGL's latest filing, from $4.2 million in the prior quarter.
Over five years, Common Equity peaked at $5.6 million in Q2 2024 and troughed at $4.2 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Common Equity (Qtr)
1	HCA Healthcare	88.19 Bn	90.61 Bn	15.19 Bn	-6.64 Bn
2	Tenet Healthcare	21.59 Bn	21.56 Bn	4.45 Bn	6.56 Bn
3	Encompass Health	12.19 Bn	12.86 Bn	1.34 Bn	3.40 Bn
4	Davita	11.52 Bn	12.39 Bn	1.16 Bn	-765.10 Mn
5	Ensign	10.59 Bn	10.27 Bn	306.24 Mn	2.45 Bn
6	Universal Health Services	8.79 Bn	8.72 Bn	3.29 Bn	7.58 Bn
7	Pacs	7.04 Bn	6.88 Bn	338.46 Mn	1.12 Bn
8	Chemed	6.96 Bn	6.92 Bn	221.47 Mn	830.51 Mn
9	Concentra Group Holdings Parent	4.52 Bn	4.38 Bn	192.10 Mn	484.72 Mn
10	Basel Medical	98.81 Mn	98.02 Mn	-	5.03 Mn

Download Data